UY27960A1 - S - (+) - 3- (1- (2- (2,3-DIHIDRO -1H-INDOL-3-IL) ETIL) 3,6-DIHIDRO-2H-PIRIDIN-4-IL) -6-CHLORINE- 1H-INDOL AND ADDITION SLAES OF THE SAME ACID. - Google Patents

S - (+) - 3- (1- (2- (2,3-DIHIDRO -1H-INDOL-3-IL) ETIL) 3,6-DIHIDRO-2H-PIRIDIN-4-IL) -6-CHLORINE- 1H-INDOL AND ADDITION SLAES OF THE SAME ACID.

Info

Publication number
UY27960A1
UY27960A1 UY27960A UY27960A UY27960A1 UY 27960 A1 UY27960 A1 UY 27960A1 UY 27960 A UY27960 A UY 27960A UY 27960 A UY27960 A UY 27960A UY 27960 A1 UY27960 A1 UY 27960A1
Authority
UY
Uruguay
Prior art keywords
indol
dihidro
slaes
piridin
etil
Prior art date
Application number
UY27960A
Other languages
Spanish (es)
Inventor
Benny Bang-Andersen
Klaus Peter Hertel
Pernille Gundorf Drewes
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of UY27960A1 publication Critical patent/UY27960A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invención se refiere al compuesto de S-(+)-3-(1-(2,3-dihidro-1H-indol-3-il)3,6-dihidro-2H-piridin-4-il)-6-cloro-1H-indol que tiene la fórmula; o a una sal farmacéuticamente adeptable del mismo y a su uso para la preparación de una composición farmacéutica para el tratamiento de enfermedades y desórdenes que responden a la inhibición de la reabsorción de 5-HT y/o a las enfermedades y desórdenes que responden al antagonismo receptor de dopamina D4.The present invention relates to the compound of S - (+) - 3- (1- (2,3-dihydro-1H-indol-3-yl) 3,6-dihydro-2H-pyridin-4-yl) -6 -chloro-1H-indole having the formula; or a pharmaceutically acceptable salt thereof and its use for the preparation of a pharmaceutical composition for the treatment of diseases and disorders that respond to the inhibition of 5-HT reabsorption and / or diseases and disorders that respond to dopamine receptor antagonism D4

UY27960A 2002-08-29 2003-08-29 S - (+) - 3- (1- (2- (2,3-DIHIDRO -1H-INDOL-3-IL) ETIL) 3,6-DIHIDRO-2H-PIRIDIN-4-IL) -6-CHLORINE- 1H-INDOL AND ADDITION SLAES OF THE SAME ACID. UY27960A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200201272 2002-08-29

Publications (1)

Publication Number Publication Date
UY27960A1 true UY27960A1 (en) 2004-03-31

Family

ID=38812814

Family Applications (1)

Application Number Title Priority Date Filing Date
UY27960A UY27960A1 (en) 2002-08-29 2003-08-29 S - (+) - 3- (1- (2- (2,3-DIHIDRO -1H-INDOL-3-IL) ETIL) 3,6-DIHIDRO-2H-PIRIDIN-4-IL) -6-CHLORINE- 1H-INDOL AND ADDITION SLAES OF THE SAME ACID.

Country Status (3)

Country Link
AR (1) AR040908A1 (en)
TW (1) TW200406403A (en)
UY (1) UY27960A1 (en)

Also Published As

Publication number Publication date
TW200406403A (en) 2004-05-01
AR040908A1 (en) 2005-04-20

Similar Documents

Publication Publication Date Title
DE602004008098D1 (en) SUBSTITUTED 2H-Ä1,2,4ÜTRIAZOLOÄ4,3-AÜPYRAZINE AS GSK-3 INHIBITORS
ATE384058T1 (en) THIAZOLE DERIVATIVES
NO20063275L (en) Use of substituted 2-aminotetralins for the prophylaxis of Parkinson's disease
BRPI0513433A (en) hydantoin derivatives for the treatment of inflammatory disorders
SE0302760D0 (en) New compounds
PA8591701A1 (en) PIRROLOPIRIMIDINE DERIVATIVES
EA200702498A1 (en) N- (PYRIDIN-2-IL) SULPHONAMIDE DERIVATIVES
BR0312729A (en) New indole-3-sulfur derivatives
HRP20090281T1 (en) 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases
ATE411985T1 (en) SUBSTITUTED PIPERAZINES AS MODULATORS OF THE MELANOCORTIN RECEPTOR
UY30025A1 (en) SUBSTITUTED DERIVATIVES OF 2-AMINO-5,6-DIHIDRO PIRIMIDIN-4 (3H) -ONAS AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITIONS CONTAINING AND APPLICATIONS.
BRPI0411699A (en) compounds for use as a therapeutically active substance; method for the treatment and / or prophylaxis of diseases that are associated with cb1 receptor modulation and use of these compounds
EE200300403A (en) N-substituted Non-Aromatic Heterocyclic Compound, Pharmaceutical Composition Containing It, and Use of the Compound as a Pharmaceutical
UY30274A1 (en) SUBSTITUTED DERIVATIVES OF THE N- (4-METHYL-1,3-TIAZOL-2-IL) GUANIDINE, PHARMACEUTICAL FORMULATIONS CONTAINING IT AND APPLICATIONS
TW200740787A (en) (6-Fluoro-benzo[1,3]dioxolyl)-morpholin-4-yl-methanones
EA200601686A1 (en) SUBSTITUTED DERIVATIVES OF MORPHOLINE AND THIOMORFOLINE
NO20053398D0 (en) Pharmaceutical preparations of sertaconazole for vaginal use.
NO20043367L (en) Oral pharmaceutical preparation
ATE449776T1 (en) PYRROLOÄ2,3-CÜPYRIDINE DERIVATIVES
ATE467632T1 (en) PYRROLOÄ2,3-BÜPYRIDINE DERIVATIVES AS MODULATORS OF THE H3 RECEPTOR
EA200601194A1 (en) NEW DERIVATIVES OF BENZOFURANE USED FOR THE PREVENTION OR TREATMENT OF DISTURBANCES ASSOCIATED WITH 5-HT-RECEPTOR
MX2020001531A (en) Novel heterocyclic compounds as cdk8/19 inhibitors.
DE602004008959D1 (en) BENZOÄBÜÄ1,4ÜDIOXEPINDERIVATE
BRPI0411936A (en) compound, process for its preparation, pharmaceutical composition comprising the same, use of a compound, methods for the treatment and prophylaxis of central nervous system disorders, eating disorders and obesity
ATE523498T1 (en) HIV-INHIBITING 2-(4-CYANOPHENYLAMINO)PYRIMIDINE DERIVATIVES

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20150522